We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

72 hedge funds and large institutions have $345M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2013 Q2 according to their latest regulatory filings, with 72 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
72
Holders Change
+72
Holders Change %
–
% of All Funds
2.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
72
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CCM
26
Cadence Capital Management
Massachusetts
$1.23M +$1.05M +58,790 New
Geode Capital Management
27
Geode Capital Management
Massachusetts
$1.21M +$1.03M +57,724 New
CCMH
28
Cornerstone Capital Management Holdings
New York
$1.06M +$899K +50,300 New
WMSA
29
Weiss Multi-Strategy Advisers
New York
$1.05M +$894K +50,000 New
KIA
30
Kopp Investment Advisors
Minnesota
$960K +$818K +45,763 New
BIM
31
BlackRock Investment Management
Delaware
$898K +$765K +42,819 New
RFC
32
Russell Frank Company
Washington
$803K +$684K +38,295 New
OAM
33
Oxford Asset Management
United Kingdom
$725K +$617K +34,542 New
SIM
34
Spark Investment Management
New York
$688K +$586K +32,800 New
MC
35
Menta Capital
California
$652K +$555K +31,080 New
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$610K +$520K +29,077 New
BIM
37
Bogle Investment Management
Massachusetts
$594K +$507K +28,353 New
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$548K +$467K +26,112 New
PAMU
39
Pictet Asset Management (UK)
United Kingdom
$539K +$459K +25,700 New
AllianceBernstein
40
AllianceBernstein
Tennessee
$495K +$421K +23,572 New
TA
41
Teachers Advisors
New York
$460K +$392K +21,942 New
ARTA
42
A.R.T. Advisors
New York
$436K +$372K +20,802 New
Citadel Advisors
43
Citadel Advisors
Florida
$397K +$338K +18,919 New
IAM
44
Iridian Asset Management
Connecticut
$397K +$338K +18,920 New
Nomura Holdings
45
Nomura Holdings
Japan
$309K +$263K +14,707 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$307K +$262K +14,634 New
DCM
47
Driehaus Capital Management
Illinois
$307K +$262K +14,638 New
VOYA Investment Management
48
VOYA Investment Management
Georgia
$298K +$254K +14,215 New
Manulife (Manufacturers Life Insurance)
49
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$296K +$253K +14,135 New
EMG
50
Ellington Management Group
Connecticut
$294K +$250K +14,000 New
1
2
3

SGNT Hedge Fund Activity: Q2 2013 in Review

72 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q2 2013, worth a combined $345M.

Buyers outnumbered sellers: 72 funds opened new SGNT positions and 0 closed out — a net gain of 72 holders — while 0 added to existing stakes and 0 trimmed.

  • 72 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $345M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q2 2013.
  • 72 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q2 2013 and 0 closed out, a net change of +72 holders.

Based on aggregated 13F filings for Q2 2013.